期刊文献+

钆塞酸二钠对比剂增强MR在小肝癌诊断中的应用 被引量:2

Application of gadoxetic acid disodium enhanced MR scan in the diagnosis of smal hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨钆塞酸二钠(Gd-EOB-DTPA)对比剂在磁共振(MR)增强扫描中对小肝癌诊断的应用价值。方法:收集41例经临床或病理证实的小肝癌患者,对所有患者行MR平扫加Gd-EOBDTPA对比剂增强扫描,分析其影像学表现。结果:在41例小肝癌患者中共检出病灶49枚,单枚病灶35例,2枚病灶4例,多枚病灶2例。MR平扫中,T_1WI和T_2WI信号特点以稍长T_1稍长T_2为主(占51.2%),DWI以稍高或高信号为主(占78.0%)。Gd-EOB-DTPA增强MR中,动脉期高信号比例为63.4%,门脉期等信号为61.0%,延迟期稍低信号及低信号为90.2%,肝胆期低信号为92.7%。全部病灶的平扫准确率为78.0%,动态增强时段的前三期为85.4%,动态增强肝胆期达100%。结论:Gd-EOB-DTPA增强MR对小肝癌的诊断准确性高,尤其表现在动态增强MR肝胆期。 Objective:To discuss the application value of contrast agent of gadoxetic acid disodium(Gd-EOB-DTPA)in the diagnosis of small hepatocellular carcinoma by using MR enhanced scan.Methods:41patients with small hepatocellular carcinoma who were confirmed by clinical surgery or pathological experiment were enrolled in this research.And all of them were implemented MR plain scan and Gd-EOB-DTPA contrast enhanced MR scan,respectively.And then these relevant imaging manifestations were analyzed.Results:A total of49lesions were found out from41patients,among whom35patients were single lesion,4patients were2lesions and2patients were multiple lesions.In MR plain scan,the signal characteristics of T1WI and T2WI were that slight long T1and slight long T2were main part(51.2%),and main manifestation of DWI was slight high or high signal(78.0%).While in Gd-EOB-DTPA contrast enhanced MR scan,the high signal ratio of arterial phase was63.4%,the equisignal ratio of portal vein phase was61.0%,the slight low and low signal ratio of delayed phase was90.2%,and the low signal ratio of hepatobiliary phase was92.7%.And the accuracy rate of plain scan for all of lesions was78.0%,and the top three stages of dynamically enhanced phase was85.4%,and the hepatobiliary stage of dynamic enhanced phase was100%.Conclusion:Gd-EOBDTPA enhanced MR has high accuracy in diagnosis for small hepatocellular carcinoma,especially in the hepatobiliary phase of dynamic enhanced MR.
作者 杨军 吴建伟 张艳 陈小军 YANG Jun;WU Jian-wei;ZHANG Yan(Department of Imaging, The 81th Hospital of PLA, Nanjing 210002, China)
机构地区 解放军第
出处 《中国医学装备》 2017年第8期65-68,共4页 China Medical Equipment
基金 全军医药卫生科研基金(11MA049)"钆塞酸二钠增强评估肝脏功能的可行性"
关键词 小肝癌 钆塞酸二钠 动态增强磁共振成像 Small hepatocellular carcinoma Gadoxetic acid disodium(Gd-EOB-DTPA) Dynamic contrast-enhanced magnetic resonance imaging
  • 相关文献

参考文献9

二级参考文献106

  • 1Masahiro Okada,Kazunari Ishii,Kazushi Numata,Tomoko Hyodo,Seishi Kumano,Masayuki Kitano,Masatoshi Kudo,Takamichi Murakami.Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function?[J].Hepatobiliary & Pancreatic Diseases International,2012,11(3):307-313. 被引量:13
  • 2高纪东,邵永孚,吴健雄,单毅,蔡建强.肝细胞癌肝切除术后预后影响因素分析[J].中华肝胆外科杂志,2005,11(8):515-517. 被引量:17
  • 3程伟中,曾蒙苏.新型多功能磁共振对比剂Gd-EOB-DTPA在肝胆系统病变中的应用[J].临床放射学杂志,2005,24(12):1107-1110. 被引量:15
  • 4杨广顺,杨宁.肝脏深部微小肝癌的处理[J].中国实用外科杂志,2006,26(9):664-665. 被引量:3
  • 5Vasanawala SS. MRI of the liver how to do it[J]. Pecliatr Ra- diol,2010,40(4) ;431-437.
  • 6Kanematsu M, Kondo H, Goshima S, et al. Magnetic resonance imaging of hepatocellular carcinoma[J]. Oncology, 2008,75 ( suppl 1) :65-71.
  • 7Balci NC, Semelka RC. Contrast agents for MR imaging of the liver[J].Radiol Clin North Am,2005,43(5) :887-898.
  • 8Reimer P, Schneider G, Schima W. Hepatobiliary contrast agentsfor contrast-enhanced MRI of the liver: properties, clinical deve- lopment and applications[J]. Eur Radiol, 2004,14(4) : 559-578.
  • 9Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, et al. Pre- clinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system[J]. Radiology: 1992,183 (l):59 -64.
  • 10Reimer P,Rummeny EJ,Shamsi K, et al. Phase clinical evalua tion of Gd-EOB-DTPA: dose, safety aspects and pulse sequence[J].Radiology, 1996,199 (1): 177-183.

共引文献601

同被引文献26

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部